Drug intelligence / Profile preview

cetirizine + phenylephrine

Development stage
Unknown
Lead developer
Apostle Remedies
Modality
Small Molecules
Administration
Oral
01

Overview

Locet-D is a fixed-dose combination of the second-generation antihistamine cetirizine and the sympathomimetic nasal decongestant phenylephrine. Developed by Apostle Remedies, it is indicated for the symptomatic relief of allergic rhinitis, seasonal allergies, and nasal congestion. Cetirizine acts as a selective antagonist of peripheral histamine H1 receptors, preventing the allergic cascade that causes sneezing, runny nose, and watery eyes. Phenylephrine acts as a selective agonist of alpha-1 adrenergic receptors, inducing vasoconstriction in the nasal passages to reduce swelling and alleviate congestion. The combination is marketed as an oral tablet formulation.

Brand names
Alnix PlusLocet DLocet-DZyriz Plus
Other names
cetirizine and phenylephrinecetirizine hydrochloride + phenylephrine hydrochloride
02

Targets

ADRA1B (α1B)ADRA1D (α1D)ADRB1 (β1)HRH1 (Histamine H1 Receptor)HRH2 (Histamine H2 Receptor)ADRA1A (α1A)

Beyond the preview

Go deeper on cetirizine + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cetirizine + phenylephrine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call